Kenneth Kita1, Steven Carlson1, Mary Huntsinger1, Han Tun1, Jina Sohn1, Rahul N Doshi2. 1. University of Southern California, Keck School of Medicine, 1510 San Pablo Street, Suite 320, Los Angeles, CA, 90033, USA. 2. University of Southern California, Keck School of Medicine, 1510 San Pablo Street, Suite 320, Los Angeles, CA, 90033, USA. Rahul.Doshi@med.usc.edu.
Abstract
OBJECTIVE: To demonstrate the feasibility of combining left atrial appendage electrical isolation (LAAEI) with left atrial appendage occlusion (LAAO) to increase efficacy of persistent/longstanding atrial fibrillation (PLAF) catheter ablation (CA) while mitigating risk of left atrial appendage (LAA) thrombus. BACKGROUND: CA for atrial fibrillation (AF) plus LAAO is safe and feasible. LAAEI may improve freedom from recurrence in PLAF but may increase LAA thrombus. METHODS: We performed 42 concomitant procedures in patients with PLAF. After standard lesions, LAAEI was performed. LAAO immediately followed ablation. If 3-month transesophageal echocardiogram (TEE) was benign, oral anticoagulation (OAC) was transitioned to dual antiplatelet therapy for 3 more months. RESULTS: Patients were 71.1 ± 8.5 years old, with CHADS2-VASc of 3.3 ± 1.1 and HAS-BLED of 2.5 ± 1.4. Twenty-eight of 42 patients (66.7%) were completely AF free over an average follow-up of 18.6 ± 8.6 months. The AF-free survival estimate was 94.5% at 1 year. There was no thromboembolism (TE) during the follow-up. There were six non-significant leaks acutely and six non-significant leaks at 6 months. There were three device-related thrombi, although 2/3 stopped OAC prematurely. CONCLUSION: A combined procedure is feasible and effective in treating arrhythmia and stroke risk associated with PLAF. The risk of TE despite OAC after LAAEI supports simultaneous LAAO.
OBJECTIVE: To demonstrate the feasibility of combining left atrial appendage electrical isolation (LAAEI) with left atrial appendage occlusion (LAAO) to increase efficacy of persistent/longstanding atrial fibrillation (PLAF) catheter ablation (CA) while mitigating risk of left atrial appendage (LAA) thrombus. BACKGROUND: CA for atrial fibrillation (AF) plus LAAO is safe and feasible. LAAEI may improve freedom from recurrence in PLAF but may increase LAA thrombus. METHODS: We performed 42 concomitant procedures in patients with PLAF. After standard lesions, LAAEI was performed. LAAO immediately followed ablation. If 3-month transesophageal echocardiogram (TEE) was benign, oral anticoagulation (OAC) was transitioned to dual antiplatelet therapy for 3 more months. RESULTS:Patients were 71.1 ± 8.5 years old, with CHADS2-VASc of 3.3 ± 1.1 and HAS-BLED of 2.5 ± 1.4. Twenty-eight of 42 patients (66.7%) were completely AF free over an average follow-up of 18.6 ± 8.6 months. The AF-free survival estimate was 94.5% at 1 year. There was no thromboembolism (TE) during the follow-up. There were six non-significant leaks acutely and six non-significant leaks at 6 months. There were three device-related thrombi, although 2/3 stopped OAC prematurely. CONCLUSION: A combined procedure is feasible and effective in treating arrhythmia and stroke risk associated with PLAF. The risk of TE despite OAC after LAAEI supports simultaneous LAAO.
Entities:
Keywords:
Atrial fibrillation; Catheter ablation; Left atrial appendage; Left atrial appendage occlusion; Watchman™
Authors: P Dorian; W Jung; D Newman; M Paquette; K Wood; G M Ayers; J Camm; M Akhtar; B Luderitz Journal: J Am Coll Cardiol Date: 2000-10 Impact factor: 24.094
Authors: Varuna K Gadiyaram; Sanghamitra Mohanty; Carola Gianni; Chintan Trivedi; Amin Al-Ahmad; David J Burkhardt; Joseph G Gallinghouse; Patrick M Hranitzky; Rodney P Horton; Javier E Sanchez; Domenico G Della Rocca; Luigi Di Biase; Matthew J Price; Linda Couts; Douglas Gibson; Andrea Natale Journal: J Cardiovasc Electrophysiol Date: 2019-01-15
Authors: Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane Journal: Heart Rhythm Date: 2017-05-12 Impact factor: 6.343
Authors: Sandeep Panikker; Julian W E Jarman; Renu Virmani; Robert Kutys; Shouvik Haldar; Eric Lim; Charles Butcher; Habib Khan; Lilian Mantziari; Edward Nicol; John P Foran; Vias Markides; Tom Wong Journal: Circ Arrhythm Electrophysiol Date: 2016-07
Authors: G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi Journal: Lancet Date: 1996-08-17 Impact factor: 79.321
Authors: Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Sanghamitra Mohanty; Javier E Sanchez; Chintan Trivedi; Mahmut Güneş; Yalçın Gökoğlan; Carola Gianni; Rodney P Horton; Sakis Themistoclakis; G Joseph Gallinghouse; Shane Bailey; Jason D Zagrodzky; Richard H Hongo; Salwa Beheiry; Pasquale Santangeli; Michela Casella; Antonio Dello Russo; Amin Al-Ahmad; Patrick Hranitzky; Dhanunjaya Lakkireddy; Claudio Tondo; Andrea Natale Journal: J Am Coll Cardiol Date: 2016-11-01 Impact factor: 24.094
Authors: Aneesh Dhorepatil; Angela L Lang; Min Lang; Muhammad Butt; Amit Arbune; David Hoffman; Soufian Almahmeed; Ohad Ziv Journal: Front Cardiovasc Med Date: 2021-12-09